Dow Up 2.00% Nasdaq Up 1.66%

Alimera Sciences, Inc. (ALIM)

-NasdaqGM
2.15 Up 0.10(4.88%) Feb 12, 4:00PM EST
Prev Close:2.05
Open:2.09
Bid:1.85 x 3000
Ask:3.25 x 200
1y Target Est:9.00
Beta:2.19185
Earnings Date:Mar 2 - Mar 7 (Est.)
Day's Range:1.99 - 2.17
52wk Range:1.75 - 5.48
Volume:45,340
Avg Vol (3m):213,277
Market Cap:95.77M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALIM

Comparison

Symbol% ChgMkt Cap
ALIMUp 4.88%95.77M
AGNUp 2.16%110.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.66
Quarterly EPS Est (Dec-15) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback